Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Amplification of KRAS in a low grade glioma

ABSTRACT: We describe the case of a low grade glioma in a 37 year old male patient showing an amplification of KRAS

ORGANISM(S): Homo sapiens

PROVIDER: GSE89982 | GEO | 2016/11/18

SECONDARY ACCESSION(S): PRJNA354337

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Simultaneous amplification and mutation of KRAS: a therapeutic target in a rare subgroup of glioblastoma?

Project description:We describe the case of a glioblostoma multiform in a 66 year old female patient showing both amplification and mutation (exon 3; codon 61) of KRAS.

2015-09-19 | GSE73199 | GEO

Simultaneous amplification and mutation of KRAS: a therapeutic target in a rare subgroup of glioblastoma?

Project description:We describe the case of a glioblostoma multiform in a 66 year old female patient showing both amplification and mutation (exon 3; codon 61) of KRAS. sample was analysed by arrayCGH method using Agilent recommendations. Sample was labeled in Cy5 and co-hybridized with control DNA cy3 labeled.

2015-09-19 | E-GEOD-73199 | biostudies-arrayexpress

RNA seq of mouse low grade glioma tumors

Project description:RNA sequencing was performed on paraffin embedded mouse low grade glioma tumor tissue

2022-09-12 | GSE172391 | GEO

Regulatory Landscape and Clinical Implication of MBD3 in Human Malignant Glioma [low-grade glioma and glioblastoma screening]

Project description:A comprehensive study is conducted to inspect the role and function of methyl-CpG-binding domain protein 3 (MBD3) in human malignant glioma, as well as to test its potential as a novel prognostic biomarker. Using whole-genome microarray for transcriptome, the MBD3-mediated epigenetic regulation in glioma was profiled.

2016-11-08 | GSE79876 | GEO

Identification of gene expression pattern for glioma stem cells in low grade glioma

Project description:Gioma stem cells from Nf1-associated optic gliomas and NSCs from third ventricle zone show differencies in gene expression patterns and physiological functions. We used microarrays to identify differential gene expression between glioma stem cells and the control counterparts including the wild type and Nf1-/- neural stem cells from the third ventricle.

2014-12-01 | GSE58260 | GEO

IDH1-R132H Low Grade Glioma animal brain tumors

Project description:IDH1-R132H Low Grade Glioma animal brain tumors

| PRJNA374999 | ENA

Genomic evolution of low and high grade glioma

Project description:Genomic evolution of low and high grade glioma

| PRJNA634165 | ENA

Genomic evolution of low and high grade glioma

Project description:Genomic evolution of low and high grade glioma

| PRJNA634166 | ENA

International Glioma Case-Control Study

Project description:International Glioma Case-Control Study

| PRJNA377600 | ENA

Low- and high-grade glioma-associated vascular cells differentially regulate tumor growth [project1]

Project description:Glioma vascular cells (GVC) from high-grade IV gliomas (HG) are molecularly and functionally distinct from normal brain EC, and secrete higher levels of pro-tumorigenic factors that promote glioma growth and progression. However, it remains unclear whether GVC from Low- Grade II/II gliomas (LG) also express pro-tumorigenic factors, and to what extent they functionally contribute to glioma growth. Here, we profile the transcriptomes of GVC from IDH-mutant (mIDH) LG and IDH-wildtype (wIDH) HG and show that they exhibit significant molecular and functional heterogeneity. LG-GVC show enrichment of extracellular matrix and cell cycle-related gene sets and sensitivity to anti-angiogenic drugs, whereas HG-GVC display an increase in immune response-related gene sets and anti-angiogenic resistance. Strikingly, conditioned media from LG-GVC inhibits the growth of wIDH glioblastoma cells, whereas HG-GVC promotes growth. In vivo co-transplantation of LG-GVC with tumor cells reduces growth, whereas HG-GVC enhances tumor growth in orthotopic xenografts. We identify ASPORIN (ASPN), a small leucine-rich repeat proteoglycan, enriched in LG-GVC as a growth suppressor of wIDH glioblastoma cells in vitro and in vivo. Together, these findings indicate that GVC from LG and HG gliomas are heterogeneous and differentially regulate tumor growth.

2024-07-10 | GSE236568 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data